Clinical Trial Update: PET Imaging Targeting Granzyme B Predicts Immunotherapy Efficacy in Diffuse Large B-cell Lymphoma

View source ↗

Summary

A clinical trial exploring Granzyme B–targeted PET imaging to predict immunotherapy efficacy in diffuse large B-cell lymphoma, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Snippet

Sponsor: Ruijin Hospital | Conditions: Diffuse Large B-Cell Lymphoma | Status: RECRUITING